Hydroxyzine Pamoate
Product Images NDC 51655-725

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydroxyzine Pamoate (NDC 51655-725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (238d1dcc 5db1 4e6f A75f 4cfcaa5b590a 01)

FDA Label Image

Image (238d1dcc 5db1 4e6f A75f 4cfcaa5b590a 02)

FDA Label Image

Label (51655 725 52 Master Bottle Label Approval Rev A 06 21)

Label (51655 725 52 Master Bottle Label Approval   Rev A 06 21)
NDC 51655-725-52 is a prescription medication containing 30 capsules of HydrOXYzine Pamoate, each capsule contains 25 mg of the active ingredient. The medication is tartrazine dye-free and stored in controlled room temperature (20° - 25°C or 687 - 77°F). This product is manufactured by Avet Pharmaceuticals Inc, Lot 0000000000 and repackaged by Northwind Pharmaceuticals in Indianapolis, IN. It is important to store this medication in its original container, and keep it out of reach of children. The expiration date is not available. Consult package insert for dosage instructions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.